VPRBP Polyclonal antibody 11612-1-AP proteintech

$149.00
In stock
SKU
11612-1-AP
Catalog No.SizePrice (USD)
11612-1-AP-20UL20 μL$149.00
11612-1-AP-150UL150 μL$449.00
Catalog Number11612-1-AP
SynonymsDCAF1, DDB1- and CUL4-associated factor 1, EC:2.7.11.1, HIV 1 Vpr binding protein, HIV-1 Vpr-binding protein
HostRabbit
Reactivityhuman, mouse and More (1)
Reactivityhuman, mouse, canine
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, FC (Intra), IP, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inDU 145 cells, HeLa cells, mouse testis tissue, PC-3 cells, HEK-293 cells, K-562 cells, HepG2 cells
Tested Applications — Positive IP detected inHeLa cells
Tested Applications — Positive IHC detected inhuman prostate cancer tissue, mouse testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inHeLa cells
Tested Applications — Positive FC (Intra) detected inHeLa cells
Recommended Dilutions — Western Blot (WB)WB : 1:1000-1:8000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:50-1:1000
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Recommended Dilutions — Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
Positive WB detected inDU 145 cells, HeLa cells, mouse testis tissue, PC-3 cells, HEK-293 cells, K-562 cells, HepG2 cells
Positive IP detected inHeLa cells
Positive IHC detected inhuman prostate cancer tissue, mouse testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells
Positive FC (Intra) detected inHeLa cells
Western Blot (WB)WB : 1:1000-1:8000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:1000
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
Tested Reactivityhuman, mouse
Cited Reactivityhuman, mouse, canine
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag2184 Product name: Recombinant human VPRBP protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 707-1058 aa of BC022792 Sequence: WSQPLSALWGMKSVFDMKHSFTEDHYVEFSKHSQDRVIGTKGDIAHIYDIQTGNKLLTLFNPDLANNYKRNCATFNPTDDLVLNDGVLWDVRSAQAIHKFDKFNMNISGVFHPNGLEVIINTEIWDLRTFHLLHTVPALDQCRVVFNHTGTVMYGAMLQADDEDDLMEERMKSPFGSSFRTFNATDYKPIATIDVKRNIFDLCTDTKDCYLAVIENQGSMDALNMDTVCRLYEVGRQRLAEDEDEEEDQEEEEQEEEDDDEDDDDTDDLDELDTDQLLEAELEEDDNNENAGEDGDNDFSPSDEELANLLEEGEDGEDEDSDADEEVELILGDTDSSDNSDLEDDIILSLNE Predict reactive species
Full NameVpr (HIV-1) binding protein
Calculated Molecular Weight1506 aa, 169 kDa
Observed Molecular Weight169 kDa
GenBank Accession NumberBC022792
Gene SymbolVPRBP
Gene ID (NCBI)9730
RRIDAB_2216933
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDQ9Y4B6
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
FC protocol for VPRBP antibody 11612-1-APDownload protocol
IF protocol for VPRBP antibody 11612-1-APDownload protocol
IHC protocol for VPRBP antibody 11612-1-APDownload protocol
IP protocol for VPRBP antibody 11612-1-APDownload protocol
WB protocol for VPRBP antibody 11612-1-APDownload protocol
humanWB Cell Host Microbe Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production. Authors - Michael Mashiba View Article
mouse,humanWB,IF Mol Cell CRL4(VprBP) E3 Ligase Promotes Monoubiquitylation and Chromatin Binding of TET Dioxygenases. Authors - Tadashi Nakagawa KD Validated View Article
Santosh (Verified Customer) (10-24-2024)Antibody works well with quite nice in westernblot. Applications: Western Blot Primary Antibody Dilution: 1:2000
Roy (Verified Customer) (06-13-2024)Great antibody detecting DCAF1 (VPRBP) validated in our coIP/WB experiments (1/1000 diluation - 1h incubation at RT) Applications: Western Blot Primary Antibody Dilution: 1/1000 Cell Tissue Type: HeLa cells
Nikhil (Verified Customer) (09-17-2019)Very good for both IP and western blot. Applications: Western Blot, Immunofluorescence, Immunoprecipitation, Primary Antibody Dilution: 1:1000 Cell Tissue Type: Colon cancer cells VPRBP Antibody Western Blot,Immunofluorescence,Immunoprecipitation, validation (1:1000 dilution) in Colon cancer cells (Cat no:11612-1-AP)
Citations51
DilutionsWB : 1:1000-1:8000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC : 1:50-1:1000 IF/ICC : 1:200-1:800 FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

VprBP was first identified as a protein that can interact with HIV-1 viral protein R (PMID: 11223251). It is a component of the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex that could interact with HIV-1 virus Vpr protein and HIV-2 virus Vpx protein (PMID: 18332868; 17314515; 18606781). VprBP is a 1,507-amino acid protein that contains conserved domains, including YXXY repeats, the Lis homology motif, and WD40 repeats. Through binding to Vpr, VprBP allows Vpr to modulate the catalytic activity of the CUL4-DDB1 complex, which in turn leads to the induction of G2 phase arrest in the virus-infected cells (PMID: 17630831). Recently it has been reported that VprBP is able to regulate the p53-induced transcription and apoptotic pathway (PMID: 22184063). Protocols Product Specific Protocols FC protocol for VPRBP antibody 11612-1-AP Download protocol IF protocol for VPRBP antibody 11612-1-AP Download protocol IHC protocol for VPRBP antibody 11612-1-AP Download protocol IP protocol for VPRBP antibody 11612-1-AP Download protocol WB protocol for VPRBP antibody 11612-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. CRL4 complex regulates mammalian oocyte survival and reprogramming by activation of TET proteins.
    Journal: Science | Authors: Chao Yu KD Validated | Species: human | Application: WB,IHC,IF
  2. CRL4(VprBP) E3 Ligase Promotes Monoubiquitylation and Chromatin Binding of TET Dioxygenases.
    Journal: Mol Cell | Authors: Tadashi Nakagawa KD Validated | Species: mouse,human | Application: WB,IF
  3. Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication.
    Journal: Mol Cell | Authors: Lei Lv KD Validated | Species: human | Application: WB
  4. Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex.
    Journal: Nat Microbiol | Authors: Leonid Yurkovetskiy | Species: human | Application: WB
  5. HIV Vpr activates a nucleolar-specific ATR pathway to degrade the nucleolar stress sensor CCDC137
    Journal: Nucleic Acids Res | Authors: Karly A Nisson | Species: human | Application: WB
  6. Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production.
    Journal: Cell Host Microbe | Authors: Michael Mashiba | Species: human | Application: WB
  7. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms.
    Journal: Nat Commun | Authors: Zengli Guo | Species: mouse | Application: WB,IP
  8. HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
    Journal: Nat Commun | Authors: Maria C Virgilio | Species: human | Application: WB
  9. Isoform-specific and ubiquitination dependent recruitment of Tet1 to replicating heterochromatin modulates methylcytosine oxidation
    Journal: Nat Commun | Authors: María Arroyo | Species: human | Application: WB,IP,IF
  10. CRL4(VprBP) E3 Ligase Promotes Monoubiquitylation and Chromatin Binding of TET Dioxygenases.
    Journal: Mol Cell | Authors: Tadashi Nakagawa | Species: mouse,human | Application: WB,IF
  11. Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication.
    Journal: Mol Cell | Authors: Lei Lv | Species: human | Application: WB
  12. Molecular recording of cellular protein kinase activity with chemical labeling
    Journal: Nat Chem Biol | Authors: De-En Sun | Species: human | Application: WB
  13. HIV Vpr activates a nucleolar-specific ATR pathway to degrade the nucleolar stress sensor CCDC137
    Journal: Nucleic Acids Res | Authors: Karly A Nisson | Species: human | Application: WB
  14. STK39 inhibits antiviral immune response by inhibiting DCAF1-mediated PP2A degradation
    Journal: Acta Pharm Sin B | Authors: Chengfei Zhang | Species: human | Application: WB
  15. DCAF1 regulates Treg senescence via the ROS axis during immunological ageing.
    Journal: J Clin Invest | Authors: Zengli Guo | Species: human | Application: WB,IP
  16. CSN6 Promotes Pancreatic Cancer Progression and Gemcitabine Resistance via Antagonizing DCAF1-Mediated Ubiquitination of NPM1.
    Journal: Adv Sci (Weinh) | Authors: Yijing Zhang | Species: human | Application: WB
  17. Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML.
    Journal: Cell Death Dis | Authors: Feifei Zhang | Species: human | Application: WB
  18. HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells.
    Journal: Cell Rep | Authors: Ann-Kathrin Reuschl | Species: human | Application: WB
  19. Linker Histone H1.2 cooperates with Cul4A and PAF1 to drive H4K31 ubiquitylation-mediated transactivation.
    Journal: Cell Rep | Authors: Kyunghwan Kim | Species: human | Application: WB
  20. DOT1L/H3K79me2 represses HIV-1 reactivation via recruiting DCAF1
    Journal: Cell Rep | Authors: Fenfei Liang | Species: human | Application: WB
  21. The Epithelial Circumferential Actin Belt Regulates YAP/TAZ through Nucleocytoplasmic Shuttling of Merlin.
    Journal: Cell Rep | Authors: Kana T Furukawa | Species: human | Application: WB,IF
  22. Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.
    Journal: Clin Sci (Lond) | Authors: Wang Bo-Shi BS | Species: human | Application: WB,IHC
  23. The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA.
    Journal: PLoS Biol | Authors: Asif A Dar | Species: mouse | Application: WB
  24. DNA damage induced by HIV-1 Vpr triggers epigenetic remodeling and transcriptional programs to enhance virus transcription and latency reactivation.
    Journal: PLoS Biol | Authors: Nicholas Saladino | Species: human | Application: IF
  25. Adenovirus Remodeling of the Host Proteome and Host Factors Associated with Viral Genomes
    Journal: mSystems | Authors: Joseph M. Dybas | Species: human | Application: WB
  26. TET1 inhibits cell proliferation by inducing RASSF5 expression.
    Journal: Oncotarget | Authors: Bo-Tai Li | Species: human | Application: WB,IHC
  27. Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes.
    Journal: PLoS Pathog | Authors: David R Collins | Species: human | Application: WB
  28. Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation.
    Journal: PLoS Pathog | Authors: Dominik Hotter | Species: human | Application: WB
  29. The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma.
    Journal: Cancers (Basel) | Authors: Jade Lyons Rimmer | Species: human | Application: IHC
  30. VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer.
    Journal: Mol Oncol | Authors: Nikhil Baban Ghate | Species: mouse,human | Application: WB
  31. VprBP regulates osteoclast differentiation via an epigenetic mechanism involving histone H2A phosphorylation
    Journal: Epigenetics Chromatin | Authors: Yonghwan Shin | Application: WB
  32. HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis.
    Journal: J Biol Chem | Authors: Delowar Hossain | Species: human | Application: WB
  33. Deciphering lentiviral Vpr/Vpx determinants required for HUSH and SAMHD1 antagonism highlights the molecular plasticity of these evolutionary conflicts
    Journal: J Virol | Authors: Pauline Larrous | Species: human | Application: WB
  34. Degradation of SAMHD1 by Vpx is Independent of Uncoating.
    Journal: J Virol | Authors: Paula Jáuregui | Species: human | Application: WB
  35. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon.
    Journal: Retrovirology | Authors: Pertel Thomas T | Species: human | Application: WB
  36. Ubiquitin E3 Ligase CRL4CDT2/DCAF2 as a Potential Chemotherapeutic Target for Ovarian Surface Epithelial Cancer.
    Journal: J Biol Chem | Authors: Pan Wei-Wei WW | Species: human | Application: IHC
  37. HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis.
    Journal: J Biol Chem | Authors: Delowar Hossain | Species: human | Application: WB
  38. VprBP (DCAF1) Regulates RAG1 Expression Independently of Dicer by Mediating RAG1 Degradation.
    Journal: J Immunol | Authors: N Max Schabla | Species: mouse | Application: WB
  39. RACK1 is required for normal B cell development and signaling but not RAG1 degradation
    Journal: J Immunol | Authors: Victoria L Palmer | Application: WB
  40. Characterization of the interactions between SIVrcm Vpx and red-capped mangabey SAMHD1.
    Journal: Biochem J | Authors: Jian Li | Species: human | Application: WB
  41. Huntingtin-Interacting Protein 1 Promotes Vpr-Induced G2 Arrest and HIV-1 Infection in Macrophages.
    Journal: Viruses | Authors: Tomoyuki Murakami | Species: human | Application: IP
  42. Tumor suppressor protein Lgl mediates G1 cell cycle arrest at high cell density by forming an Lgl-VprBP-DDB1 complex.
    Journal: Mol Biol Cell | Authors: Kazunari Yamashita | Species: canine | Application: WB
  43. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens.
    Journal: Cancer Cytopathol | Authors: Yi-Zhen Liu | Species: human | Application: IHC
  44. Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail.
    Journal: Mol Cell Biol | Authors: Kim Kyunghwan K | Species: human | Application: WB
  45. Defining the Interactions and Role of DCAF1/VPRBP in the DDB1-Cullin4A E3 Ubiquitin Ligase Complex Engaged by HIV-1 Vpr to Induce a G2 Cell Cycle Arrest.
    Journal: PLoS One | Authors: Francine C A Gérard | Species: human | Application: WB
  46. Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.
    Journal: PLoS One | Authors: de Silva Suresh S | Species: human | Application: WB
  47. The CRL4VPRBP(DCAF1) E3 ubiquitin ligase directs constitutive RAG1 degradation in a non-lymphoid cell line.
    Journal: PLoS One | Authors: N Max Schabla | Species: human | Application: WB
  48. HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection.
    Journal: Virology | Authors: McCulley Anna A | Species: human | Application: WB
  49. HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
    Journal: bioRxiv | Authors: Maria C Virgilio | Species: human | Application: WB
  50. HIV-1 Vpr-induced DNA damage activates NF-κB independent of cell cycle arrest and CRL4A DCAF1 engagement
    Journal: bioRxiv | Authors: Carina Sandoval | Species: human | Application: WB
  51. HIV-1 Vpr drives epigenetic remodeling to enhance virus transcription and latency reactivation
    Journal: bioRxiv | Authors: Nicholas Saladino | Species: human | Application: WB,IF

Reviews

Write Your Own Review
You're reviewing:VPRBP Polyclonal antibody 11612-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.